Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2.

ABSTRACT:

SUBMITTER: Xie Y 

PROVIDER: S-EPMC8477624 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature